Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer-Reference-Cited by-同舟云学术

Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer

Published:2019-05-16 Issue:20 Volume:380 Page:1929-1940
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

André Fabrice¹,Ciruelos Eva¹,Rubovszky Gabor¹,Campone Mario¹,Loibl Sibylle¹,Rugo Hope S.¹,Iwata Hiroji¹,Conte Pierfranco¹,Mayer Ingrid A.¹,Kaufman Bella¹,Yamashita Toshinari¹,Lu Yen-Shen¹,Inoue Kenichi¹,Takahashi Masato¹,Pápai Zsuzsanna¹,Longin Anne-Sophie¹,Mills David¹,Wilke Celine¹,Hirawat Samit¹,Juric Dejan¹

Affiliation:

1. From Institut Gustave Roussy, INSERM Unité 981, Université Paris-Sud, Villejuif (F.A.), Institut de Cancérologie de l’Ouest, St. Herblain (M.C.), and Novartis Pharma, Paris (A.-S.L.) — all in France; Hospital Universitario 12 de Octubre, Madrid (E.C.); National Institute of Oncology (G.R.) and Duna Medical Center (Z.P.), Budapest, Hungary; German Breast Group, Neu-Isenburg, and Center for Hematology and Oncology Bethanien, Frankfurt — both in Germany (S.L.); UCSF Helen Diller Family Comprehensive Cancer...

Funder

Pharmaceuticals Corporation

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1813904

Cited by 1748 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted gene panel sequencing of liquid and tissue biopsies reveals actionable genomic alterations in Ghanaian metastatic breast cancer cases;Translational Oncology;2024-11

2. The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysis;European Journal of Pharmacology;2024-11

3. Evaluating the simultaneous electrochemical determination of antineoplastic drugs using LaNiO3/g-C3N4@RGH nanocomposite material;Talanta;2024-10

4. Synthetic approaches and application of representative clinically approved fluorine-enriched anti-cancer medications;European Journal of Medicinal Chemistry;2024-10

5. The paradox of senescent-marker positive cancer cells: challenges and opportunities;npj Aging;2024-09-14